GT200400266A - Un procedimiento de sintesis para la alquilacion reductiva en la posicion c-3 de los indoles que contienen gruposfuncionales sensibles al acido. - Google Patents
Un procedimiento de sintesis para la alquilacion reductiva en la posicion c-3 de los indoles que contienen gruposfuncionales sensibles al acido.Info
- Publication number
- GT200400266A GT200400266A GT200400266A GT200400266A GT200400266A GT 200400266 A GT200400266 A GT 200400266A GT 200400266 A GT200400266 A GT 200400266A GT 200400266 A GT200400266 A GT 200400266A GT 200400266 A GT200400266 A GT 200400266A
- Authority
- GT
- Guatemala
- Prior art keywords
- acid
- reductive
- rental
- functional groups
- containing functional
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000002253 acid Substances 0.000 title abstract 2
- 150000002475 indoles Chemical class 0.000 title abstract 2
- 230000002829 reductive effect Effects 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 241001600072 Hydroides Species 0.000 abstract 1
- -1 INDOL COMPOUND Chemical class 0.000 abstract 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 abstract 1
- 239000002841 Lewis acid Substances 0.000 abstract 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000003638 chemical reducing agent Substances 0.000 abstract 1
- 150000007517 lewis acids Chemical class 0.000 abstract 1
- 229910052710 silicon Inorganic materials 0.000 abstract 1
- 239000010703 silicon Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
UN PROCEDIMIENTO DE ALQUILACION REDUCTIVA EN AL POSICION C3 DE UN COMPUESTO INDOL EN EL CUAL EL INDOL ES TRATADO CON UN ALDEHIDO EN LA PRESENCIA DE UN ACIDO DE LEWIS Y UN AGENTE REDUCTOR DE HIDRURO DE SILICIO. EL PROCEDIMIENTO ES UTIL PARA ALQUILAR LA POSICION C3 DE LOS INDOLES QUE CONTIENEN SUBSTITUYENTES SENSIBLES AL ACIDO EN LA POSICION N1.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52979703P | 2003-12-16 | 2003-12-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT200400266A true GT200400266A (es) | 2005-08-30 |
Family
ID=34700047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT200400266A GT200400266A (es) | 2003-12-16 | 2004-12-14 | Un procedimiento de sintesis para la alquilacion reductiva en la posicion c-3 de los indoles que contienen gruposfuncionales sensibles al acido. |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US7282594B2 (es) |
| EP (1) | EP1697320B1 (es) |
| JP (1) | JP5121232B2 (es) |
| KR (2) | KR101194592B1 (es) |
| CN (1) | CN1914170B (es) |
| AR (1) | AR046895A1 (es) |
| AU (1) | AU2004299462B2 (es) |
| BR (1) | BRPI0417769B8 (es) |
| CA (1) | CA2549120C (es) |
| CR (1) | CR8446A (es) |
| EC (1) | ECSP066648A (es) |
| EG (1) | EG24473A (es) |
| GT (1) | GT200400266A (es) |
| HN (1) | HN2004000536A (es) |
| IL (1) | IL176147A (es) |
| MX (1) | MXPA06006669A (es) |
| NI (1) | NI200600132A (es) |
| NO (1) | NO20062757L (es) |
| PA (1) | PA8620101A1 (es) |
| PE (1) | PE20051012A1 (es) |
| RU (1) | RU2352560C2 (es) |
| SG (1) | SG147487A1 (es) |
| TW (1) | TW200526576A (es) |
| UA (1) | UA84445C2 (es) |
| WO (1) | WO2005058820A1 (es) |
| ZA (1) | ZA200604966B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7713964B2 (en) | 2001-12-03 | 2010-05-11 | Wyeth Llc | Methods for treating asthmatic conditions |
| US7605156B2 (en) | 2001-12-03 | 2009-10-20 | Wyeth | Methods for the use of inhibitors of cytosolic phospholipase A2 |
| TW200510305A (en) | 2003-07-25 | 2005-03-16 | Wyeth Corp | Process for the preparation of CPLA2 inhibitors |
| US7582771B2 (en) * | 2003-09-03 | 2009-09-01 | Wyeth | Process for the synthesis of cPLA2 inhibitors |
| US7342119B2 (en) * | 2003-09-30 | 2008-03-11 | Wyeth Holdings Corporation | Process for the synthesis of a CPLA2 inhibitor |
| AR053410A1 (es) * | 2004-08-19 | 2007-05-09 | Wyeth Corp | Proceso para la sintesis de indoles n-alquilados c-2, c-3 sustituidos. compuestos intermediarios |
| TW200718687A (en) | 2005-05-27 | 2007-05-16 | Wyeth Corp | Inhibitors of cytosolic phospholipase A2 |
| WO2008055136A2 (en) * | 2006-10-31 | 2008-05-08 | Wyeth | Liquid formulations of phospholipase enzyme inhibitors |
| JP2010508304A (ja) * | 2006-10-31 | 2010-03-18 | ワイス エルエルシー | ホスホリパーゼ酵素阻害剤の半固体製剤 |
| CN111087340B (zh) * | 2019-11-29 | 2021-12-07 | 上海应用技术大学 | 一种维拉佐酮中间体的制备方法 |
| WO2024221110A1 (en) * | 2023-04-27 | 2024-10-31 | 1280225 B.C. Ltd. | Methods of preparing functionalized indoles |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9026427D0 (en) * | 1990-12-05 | 1991-01-23 | Ici Plc | Chemical process |
| GB9317764D0 (en) | 1993-08-26 | 1993-10-13 | Pfizer Ltd | Therapeutic compound |
| GB9609641D0 (en) * | 1996-05-09 | 1996-07-10 | Pfizer Ltd | Compounds useful in therapy |
| US6984735B2 (en) | 2001-12-03 | 2006-01-10 | Wyeth | Process for making an aldehyde |
| US7101875B2 (en) | 2001-12-03 | 2006-09-05 | Wyeth | Methods for treating arthritic disorders |
| US6635771B2 (en) | 2001-12-03 | 2003-10-21 | Wyeth | N-benzhydryl indole compounds |
| CA2469138C (en) * | 2001-12-03 | 2012-04-17 | Wyeth | Inhibitors of cytosolic phospholipase a2 |
| US6797708B2 (en) | 2001-12-03 | 2004-09-28 | Wyeth | Inhibitors of cytosolic phospholipase A2 |
| US7713964B2 (en) | 2001-12-03 | 2010-05-11 | Wyeth Llc | Methods for treating asthmatic conditions |
| US7605156B2 (en) | 2001-12-03 | 2009-10-20 | Wyeth | Methods for the use of inhibitors of cytosolic phospholipase A2 |
| US20040182785A1 (en) * | 2002-10-23 | 2004-09-23 | Rigel Technology Corporation | Animal plasma process by precipitation |
| TW200510305A (en) * | 2003-07-25 | 2005-03-16 | Wyeth Corp | Process for the preparation of CPLA2 inhibitors |
| US7582771B2 (en) | 2003-09-03 | 2009-09-01 | Wyeth | Process for the synthesis of cPLA2 inhibitors |
| US7342119B2 (en) * | 2003-09-30 | 2008-03-11 | Wyeth Holdings Corporation | Process for the synthesis of a CPLA2 inhibitor |
| AR053410A1 (es) | 2004-08-19 | 2007-05-09 | Wyeth Corp | Proceso para la sintesis de indoles n-alquilados c-2, c-3 sustituidos. compuestos intermediarios |
| TW200718687A (en) | 2005-05-27 | 2007-05-16 | Wyeth Corp | Inhibitors of cytosolic phospholipase A2 |
-
2004
- 2004-12-05 HN HN2004000536A patent/HN2004000536A/es unknown
- 2004-12-10 PE PE2004001237A patent/PE20051012A1/es not_active Application Discontinuation
- 2004-12-14 GT GT200400266A patent/GT200400266A/es unknown
- 2004-12-15 KR KR1020067014252A patent/KR101194592B1/ko not_active Expired - Fee Related
- 2004-12-15 EP EP04814200.4A patent/EP1697320B1/en not_active Expired - Lifetime
- 2004-12-15 TW TW093138860A patent/TW200526576A/zh unknown
- 2004-12-15 MX MXPA06006669A patent/MXPA06006669A/es active IP Right Grant
- 2004-12-15 AR ARP040104672A patent/AR046895A1/es unknown
- 2004-12-15 AU AU2004299462A patent/AU2004299462B2/en not_active Ceased
- 2004-12-15 RU RU2006125447/04A patent/RU2352560C2/ru active
- 2004-12-15 UA UAA200607900A patent/UA84445C2/ru unknown
- 2004-12-15 PA PA20048620101A patent/PA8620101A1/es unknown
- 2004-12-15 CA CA2549120A patent/CA2549120C/en not_active Expired - Lifetime
- 2004-12-15 NI NI200600132A patent/NI200600132A/es unknown
- 2004-12-15 JP JP2006545820A patent/JP5121232B2/ja not_active Expired - Fee Related
- 2004-12-15 BR BRPI0417769A patent/BRPI0417769B8/pt not_active IP Right Cessation
- 2004-12-15 CN CN2004800416736A patent/CN1914170B/zh not_active Expired - Fee Related
- 2004-12-15 KR KR1020127016929A patent/KR20120082477A/ko not_active Withdrawn
- 2004-12-15 SG SG200808109-3A patent/SG147487A1/en unknown
- 2004-12-15 WO PCT/US2004/041989 patent/WO2005058820A1/en not_active Ceased
- 2004-12-16 US US11/014,657 patent/US7282594B2/en not_active Expired - Lifetime
-
2006
- 2006-06-06 IL IL176147A patent/IL176147A/en active IP Right Grant
- 2006-06-08 CR CR8446A patent/CR8446A/es not_active Application Discontinuation
- 2006-06-13 NO NO20062757A patent/NO20062757L/no not_active Application Discontinuation
- 2006-06-14 EG EGNA2006000557 patent/EG24473A/xx active
- 2006-06-15 ZA ZA2006/04966A patent/ZA200604966B/en unknown
- 2006-06-16 EC EC2006006648A patent/ECSP066648A/es unknown
-
2007
- 2007-10-15 US US11/872,193 patent/US7709661B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT200400266A (es) | Un procedimiento de sintesis para la alquilacion reductiva en la posicion c-3 de los indoles que contienen gruposfuncionales sensibles al acido. | |
| AR067613A1 (es) | Inhibidores de adn-pk, uso y sintesis de los mismos | |
| AR045234A1 (es) | Metodo para producir derivados del almidon de hidroxialquilo y composiciones farmaceuticas que los contienen. | |
| ES2220529T3 (es) | Dibenzopiranos utiles como antagonistas del receptor de los glucocorticoides, en el tratamiento de la diabetes. | |
| EP1485095A4 (en) | FLUORINATED 4-AZASTEROID DERIVATIVES AS ANDROGEN RECEPTOR MODULATORS | |
| CO6290760A2 (es) | Derivados de alcoholes de 1 fenil-2-piridinilalquilo como inbidores de la fosfodiesterasa | |
| ES2173846T3 (es) | Compuestos de biciclocarbonil indol como agentes antiinflamatorios/analgesicos y como inhibidores de cox-2. | |
| CO5690130A1 (es) | Derivados de eter biarilico que presentan actividad como inhibidores de la recaptacion de monoaminas para el tratamiento del snc | |
| GT200300015A (es) | Aza-arilpiperazinas | |
| UY29016A1 (es) | Analogos de dipeptidos inhibidores de la hepatitis c | |
| DE602004011348D1 (de) | Indanderivate als muscarinrezeptoragonisten | |
| PA8791601A1 (es) | Compuestos de biciclolactama sustituida | |
| DE602004023207D1 (de) | Benzimidazol-derivate als mek-hemmer | |
| CO5160250A1 (es) | Derivados de piridopiranoacepinas su procedimiento de sintesis y composiciones que los contienen | |
| AR059216A1 (es) | 11b-hidroxiandrosta-4-eno-3-onas | |
| UY32261A (es) | Nuevas octahidrociclopenta[c]pirrol-4-aminas sustituidas como bloqueantes de los canales de calcio | |
| ATE269848T1 (de) | Calciumkanalblocker als antikrebsmittel | |
| HN2008001934A (es) | 18-metil-19-nor-androst-4-en-17,17-espiroesteres (18-metil-19-nor-20-espirox-4-en-3-onas), asi como preparaciones farmaceuticas que los contienen. | |
| BR0113610A (pt) | Derivados da fenoxibenzilamina como inibidores seletivos de recuperação de serotonina | |
| EA200700367A1 (ru) | Новые производные 4-бензилиденпиперидина | |
| ECSP034531A (es) | Derivados sustituidos de c-ciclohexilmetilamina | |
| CO5611125A2 (es) | Derivados de azetidina como antagonistas del receptor ccr-3 | |
| DE60302554D1 (de) | Gasgenerator | |
| DE60041001D1 (de) | Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien | |
| DE60308187D1 (de) | N-benzyl-3-phenyl-3-heterocyclyl-propionamid-verbindungen als tachykinin rezeptoren antagonisten und/oder als serotoninwiederaufnahme inhibitoren |